Antagonism of regulatory ISGs enhances the anti-melanoma efficacy of STING agonists.
Filderman JN, Taylor JL, Wang J, Zhang Y, Singh P, Ross MA, Watkins SC, Nedal Al Bzour A, Karapetyan L, Kalinski P, Storkus WJ.
Filderman JN, et al. Among authors: watkins sc.
Front Immunol. 2024 Jan 18;15:1334769. doi: 10.3389/fimmu.2024.1334769. eCollection 2024.
Front Immunol. 2024.
PMID: 38312842
Free PMC article.